Bioline Rx reported $16.35M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Arca Biopharma USD 884.56M 489.31M Jun/2026
Bio Path USD 677K 14K Mar/2026
Bioline Rx USD 16.35M 5.23M Jun/2026
Capricor Therapeutics USD 242.13M 40.96M Jun/2026